Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
20.80
+0.41 (2.01%)
Last updated: Jul 14, 2025
68.83%
Market Cap 2.23B
Revenue (ttm) 194.24M
Net Income (ttm) 46.57M
Shares Out 108.22M
EPS (ttm) 0.45
PE Ratio 45.30
Forward PE n/a
Dividend 0.40 (1.95%)
Ex-Dividend Date Jun 5, 2025
Volume 1,735,199
Average Volume 1,684,059
Open 20.21
Previous Close 20.39
Day's Range 20.18 - 21.15
52-Week Range 11.87 - 23.00
Beta 0.48
RSI 57.69
Earnings Date Aug 26, 2025

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sale of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 326
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2024, SHA:688163's revenue was 194.92 million, an increase of 2.51% compared to the previous year's 190.14 million. Earnings were 44.29 million, an increase of 14.23%.

Financial Statements

News

There is no news available yet.